Kiox Pharmaceuticals ApS
CVRCVR number42886866
Core data
Name | Kiox Pharmaceuticals ApS |
Address | Stolbjergvej 26C, 3070, Snekkersten |
Founded | Dec 7, 2021 |
Locations (P-units) | 1View locations |
Branch | Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990) |
Name | Kiox Pharmaceuticals ApS |
Address | Stolbjergvej 26C, 3070, Snekkersten |
Founded | Dec 7, 2021 |
Locations (P-units) | 1View locations |
Branch | Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990) |
Keep track of Kiox Pharmaceuticals ApS
Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account
Description
The Company is a biotech Company incorporated in December 2021 focusing on development of inhaled treatments for interstitial lung diseases.
Financials
Company financials
| Reporting period | 2025DKK | |||
|---|---|---|---|---|
| Gross profit | 120,473 | |||
| Operating profit | -832,901 | |||
| Profit before tax | -838,098 | |||
| Net income | -639,537 | |||
| Total assets | 1,155,074 | |||
| Equity | -404,366 | |||
2022–2025 Unlock financial history | ||||
Datapublica Risk Score
Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
0 · Low100 · High
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Inge Tarnow | Roles Board | TitlesBESTYRELSESMEDLEM |
| Lars Hellerung Christiansen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Mikkel Walmar | Roles BoardManagement | TitlesFORMAND • DIREKTØR |
| Tim Dehli Carstensen | Roles Management | TitlesDIREKTØR |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| EY Godkendt Revisionspartnerselskab | AuditorAnders Roe Eriksen | RoleState Authorised Public Accountant | FromJun 30, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership50–66.66 % | Voting rights50 % | FromMar 23, 2026 | |
| Ownership20–24.99 % | Voting rights20 % | FromFeb 5, 2024 | |
| Ownership15–19.99 % | Voting rights15 % | FromMar 23, 2026 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| Mikkel Walmar | Ownership through | 50–66.66 % |
| Tim Dehli Carstensen | Ownership through | 20–24.99 % |
| Lars Hellerung Christiansen | Ownership through | 15–19.99 % |